V940-002 is a personalized cancer vaccine (Moderna) + pembrolizumab (Merck). The trial (link) is on patients with resected non small cell lung cancer. Will it pass phase 3 and get approval?
Get Ṁ600 play money
Related questions
Will AOH1996 be FDA approved before 2040?
43% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
38% chance
Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?
59% chance
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will an AI-designed drug get FDA approval by the end of 2025?
33% chance
Will a cancer therapy approved by the FDA before 2027 successfully cure >1 cancer type?
63% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
33% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
28% chance